Literature DB >> 7884840

A naturalistic follow-up study of French-speaking opiate-maintained heroin-addicted patients: effect on biopsychosocial status.

M Auriacombe1, D Grabot, J P Daulouède, J P Vergnolle, C O'Brien, J Tignol.   

Abstract

The purpose of this study was to evaluate the impact of opiate maintenance pharmacotherapy (OMP) on the biopsychosocial status of opiate-addicted patients in a cultural environment (France) that is not favorable to OMP and where methadone is not available. Buprenorphine and laudanum (opium tincture), which, to our knowledge, has not been reported previously in the scientific literature for OMP, were used in this study of a group of 18 opioid-dependent subjects. At time of initiation of OMP, mean age was 33 years, sex ratio male: female was 14:4, average duration of drug use was 11.2 years. Six patients received laudanum p.o., 15 g daily; 12 patients received buprenorphine sublingual 2 to 4 mg daily. This group of patients was selected because of persistent relapse and impairment after an average of 5.7 drug-free-oriented treatments over a period of 6.8 years. Initial evaluation and follow-up were made by way of a 150-min semi-structured interview using the Lifetime Retrospective Evaluation Score Table (LREST) and the Addiction Severity Index (ASI). Results showed that body weight and scores for physical and psychological health, socioprofessional status, and family relationships improved significantly after 14 months of OMP. These results show that highly impaired opiate-addicted patients doing poorly in drug-free treatment can respond to OMP even though methadone is not available and the idea of OMP is not favored.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7884840     DOI: 10.1016/0740-5472(94)90008-6

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  7 in total

1.  Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics.

Authors:  Andrew A Somogyi; Mie Larsen; Reza M Abadi; Jaroon Jittiwutikarn; Robert Ali; Jason M White
Journal:  Br J Clin Pharmacol       Date:  2008-11       Impact factor: 4.335

2.  Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre.

Authors:  Jaroon Jittiwutikarn; Robert Ali; Jason M White; Felix Bochner; Andrew A Somogyi; David J R Foster
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

3.  Comparing the Efficacy of Methadone and Tincture of Opium in Controlling Agitation Caused by Withdrawal Syndrome in Opium-Addicted Patients in the Intensive Care Unit: A Randomized Trial Study.

Authors:  Seyed Mojtaba Sohrevardi; Mostafa Pournamdari; Razieh Salimi; Farhad Sarrafzadeh; Mehdi Ahmadinejad
Journal:  Addict Health       Date:  2020-04

4.  Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy.

Authors:  T V Parran; C A Adelman; B Merkin; M E Pagano; R Defranco; R A Ionescu; A G Mace
Journal:  Drug Alcohol Depend       Date:  2009-08-29       Impact factor: 4.492

Review 5.  Why buprenorphine is so successful in treating opiate addiction in France.

Authors:  M Fatseas; Marc Auriacombe
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

6.  Maintenance therapy with opium tincture for injecting drug users; implications for prevention from viral infections.

Authors:  Zahra Alam Mehrjerdi; Mehran Zarghami
Journal:  Hepat Mon       Date:  2013-04-16       Impact factor: 0.660

7.  Maintenance Treatment with Opium Tincture: A Preliminary Qualitative Study of the Factors Related to Treatment entry.

Authors:  Reza Daneshmand; Zahra Alam Mehrjerdi; Mercede Samiee
Journal:  Iran J Public Health       Date:  2014-08       Impact factor: 1.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.